Borne's long-awaited Report on regulation of healthcare products has fallen well short of pharmaceutical industry expectations. Indeed, it contains very few concrete proposals. ...more
9/11/2023
/ Biologics ,
Biosimilars ,
Clinical Trials ,
Digital Health ,
Generic Drugs ,
Genetic Testing ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Hospitals ,
Life Sciences ,
Over The Counter Drugs (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs
Companies in the life sciences and health care industry, like most companies, navigated unparalleled challenges in 2020. But unlike other industries, they had to do so while simultaneously facing the biggest challenge of all...more